RETINALGENIX TECHNOLOGIES INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $726.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-04-15
- RETINALGENIX TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $726.00K, a 39.30% decline from fiscal 2024.
- RETINALGENIX TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.20M, a 91.05% increase from fiscal 2023.
- RETINALGENIX TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $626.00K, a 58.57% decline from fiscal 2022.
- RETINALGENIX TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $1.51M, a 288.43% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $726.00K 10-K · filed 2026-04-15 | |
| 2024-12-31 | $1.20M 10-K · filed 2026-04-15 | $1.29M 10-K · filed 2025-03-31 |
| 2023-12-31 | $626.00K 10-K · filed 2025-03-31 | |
| 2022-12-31 | $1.51M 10-K · filed 2024-04-01 | $521.00K 10-K · filed 2023-03-31 |
| 2021-12-31 | $389.00K 10-K/A · filed 2023-06-15 | |
| 2020-12-31 | $556.00K 10-K · filed 2022-04-15 | |
| 2019-12-31 | $232.00K 10-Q · filed 2021-11-22 |